Recent Progress in Neuroactive Marine Natural Products

Overview

Journal Nat Prod Rep

Publisher Royal Society of Chemistry

Date 2014 Jan 17

PMID 24430532

Citations 18

Authors

Ryuichi Sakai

Geoffrey T Swanson

Affiliations

Soon will be listed here.

Abstract

This review covers the isolation, chemical structure, biological activity, structure activity relationships including synthesis of chemical probes, and pharmacological characterization of neuroactive marine natural products; 302 references are cited.

Citing Articles

Natural Alkaloids as Multi-Target Compounds towards Factors Implicated in Alzheimer's Disease.

Vrabec R, Blunden G, Cahlikova L Int J Mol Sci. 2023; 24(5).

PMID: 36901826 PMC: 10003045. DOI: 10.3390/ijms24054399.

Benefits under the Sea: The Role of Marine Compounds in Neurodegenerative Disorders.

Catanesi M, Caioni G, Castelli V, Benedetti E, dAngelo M, Cimini A Mar Drugs. 2021; 19(1).

PMID: 33430021 PMC: 7827849. DOI: 10.3390/md19010024.

Biologically active compounds from marine organisms in the strategies for combating coronaviruses.

Zaporozhets T, Besednova N AIMS Microbiol. 2020; 6(4):470-494.

PMID: 33364539 PMC: 7755586. DOI: 10.3934/microbiol.2020028.

Marine Toxins and Nociception: Potential Therapeutic Use in the Treatment of Visceral Pain Associated with Gastrointestinal Disorders.

Baj A, Bistoletti M, Bosi A, Moro E, Giaroni C, Crema F Toxins (Basel). 2019; 11(8).

PMID: 31370176 PMC: 6723473. DOI: 10.3390/toxins11080449.

Soritesidine, a Novel Proteinous Toxin from the Okinawan Marine Sponge sp.

Sakai R, Tanano K, Ono T, Kitano M, Iida Y, Nakano K Mar Drugs. 2019; 17(4).

PMID: 30965587 PMC: 6520796. DOI: 10.3390/md17040216.

References

Wiese M, DAgostino P, Mihali T, Moffitt M, Neilan B . Neurotoxic alkaloids: saxitoxin and its analogs. Mar Drugs. 2010; 8(7):2185-211. PMC: 2920551. DOI: 10.3390/md8072185. View

Layer R, Wagstaff J, White H . Conantokins: peptide antagonists of NMDA receptors. Curr Med Chem. 2004; 11(23):3073-84. DOI: 10.2174/0929867043363901. View

Esbenshade T, Browman K, Bitner R, Strakhova M, Cowart M, Brioni J . The histamine H3 receptor: an attractive target for the treatment of cognitive disorders. Br J Pharmacol. 2008; 154(6):1166-81. PMC: 2483387. DOI: 10.1038/bjp.2008.147. View

Williams P, Sorribas A, Liang Z . New methods to explore marine resources for Alzheimer's therapeutics. Curr Alzheimer Res. 2010; 7(3):210-3. PMC: 3170562. DOI: 10.2174/156720510791050812. View

Gueret S, Brimble M . Spiroimine shellfish poisoning (SSP) and the spirolide family of shellfish toxins: isolation, structure, biological activity and synthesis. Nat Prod Rep. 2010; 27(9):1350-66. DOI: 10.1039/c005400n. View

Sawayama Y, Nishikawa T . A synthetic route to the saxitoxin skeleton: synthesis of decarbamoyl α-saxitoxinol, an analogue of saxitoxin produced by the cyanobacterium Lyngbya wollei. Angew Chem Int Ed Engl. 2011; 50(31):7176-8. DOI: 10.1002/anie.201102494. View

Martin V, Vale C, Bondu S, Thomas O, Vieytes M, Botana L . Differential effects of crambescins and crambescidin 816 in voltage-gated sodium, potassium and calcium channels in neurons. Chem Res Toxicol. 2012; 26(1):169-78. DOI: 10.1021/tx3004483. View

Hu J, Schetz J, Kelly M, Peng J, Ang K, Flotow H . New antiinfective and human 5-HT2 receptor binding natural and semisynthetic compounds from the Jamaican sponge Smenospongia aurea. J Nat Prod. 2002; 65(4):476-80. DOI: 10.1021/np010471e. View

Lash L, Sanders J, Akiyama N, Shoji M, Postila P, Pentikainen O . Novel analogs and stereoisomers of the marine toxin neodysiherbaine with specificity for kainate receptors. J Pharmacol Exp Ther. 2007; 324(2):484-96. PMC: 2796858. DOI: 10.1124/jpet.107.129890. View

10.

Ruan B, Zhu H . The chemistry and biology of the bryostatins: potential PKC inhibitors in clinical development. Curr Med Chem. 2012; 19(16):2652-64. DOI: 10.2174/092986712800493020. View

11.

Khavandgar S, Homayoun H, Dehpour A . The role of nitric oxide in the proconvulsant effect of delta-opioid agonist SNC80 in mice. Neurosci Lett. 2002; 329(2):237-9. DOI: 10.1016/s0304-3940(02)00417-2. View

12.

Ashton H, Young A . GABA-ergic drugs: exit stage left, enter stage right. J Psychopharmacol. 2003; 17(2):174-8. DOI: 10.1177/0269881103017002004. View

13.

Prorok M, Castellino F . Structure-function relationships of the NMDA receptor antagonist conantokin peptides. Curr Drug Targets. 2001; 2(3):313-22. DOI: 10.2174/1389450013348542. View

14.

Sato S, Sakai R, Kodama M . Identification of thioether intermediates in the reductive transformation of gonyautoxins into saxitoxins by thiols. Bioorg Med Chem Lett. 2000; 10(16):1787-9. DOI: 10.1016/s0960-894x(00)00332-2. View

15.

Martinez A, Gil C, Perez D . Glycogen synthase kinase 3 inhibitors in the next horizon for Alzheimer's disease treatment. Int J Alzheimers Dis. 2011; 2011:280502. PMC: 3132520. DOI: 10.4061/2011/280502. View

16.

Fone K, Nutt D . Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder. Curr Opin Pharmacol. 2005; 5(1):87-93. DOI: 10.1016/j.coph.2004.10.001. View

17.

Hanifin C . The chemical and evolutionary ecology of tetrodotoxin (TTX) toxicity in terrestrial vertebrates. Mar Drugs. 2010; 8(3):577-93. PMC: 2857372. DOI: 10.3390/md8030577. View

18.

Hauser T, Hepler C, Kombo D, Grinevich V, Kiser M, Hooker D . Comparison of acetylcholine receptor interactions of the marine toxins, 13-desmethylspirolide C and gymnodimine. Neuropharmacology. 2012; 62(7):2239-50. DOI: 10.1016/j.neuropharm.2012.01.009. View

19.

Manger R, Leja L, Lee S, Hungerford J, Hokama Y, Dickey R . Detection of sodium channel toxins: directed cytotoxicity assays of purified ciguatoxins, brevetoxins, saxitoxins, and seafood extracts. J AOAC Int. 1995; 78(2):521-7. View

20.

Lynch J . Native glycine receptor subtypes and their physiological roles. Neuropharmacology. 2008; 56(1):303-9. DOI: 10.1016/j.neuropharm.2008.07.034. View